Sientra, Inc. (SIEN) Sees Strong Trading Volume
Shares of Sientra, Inc. (NASDAQ:SIEN) saw unusually-strong trading volume on Wednesday . Approximately 789,611 shares were traded during mid-day trading, an increase of 264% from the previous session’s volume of 217,123 shares.The stock last traded at $15.01 and had previously closed at $12.58.
Several analysts have issued reports on SIEN shares. Zacks Investment Research lowered Sientra from a “hold” rating to a “sell” rating in a research note on Tuesday, August 15th. ValuEngine upgraded Sientra from a “sell” rating to a “hold” rating in a research note on Thursday, June 22nd. Lake Street Capital reiterated a “buy” rating and set a $15.00 target price (up previously from $11.00) on shares of Sientra in a research note on Tuesday, August 8th. Stephens initiated coverage on Sientra in a research note on Tuesday, July 11th. They set an “overweight” rating and a $12.00 target price on the stock. Finally, William Blair upgraded Sientra from a “market perform” rating to an “outperform” rating in a research note on Wednesday. One analyst has rated the stock with a sell rating, one has issued a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $13.67.
The stock’s market cap is $284.76 million. The firm has a 50-day moving average price of $11.20 and a 200 day moving average price of $9.39.
Sientra (NASDAQ:SIEN) last posted its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported ($0.55) EPS for the quarter, topping analysts’ consensus estimates of ($0.59) by $0.04. The company had revenue of $8.20 million for the quarter, compared to analysts’ expectations of $6.97 million. Sientra had a negative net margin of 173.83% and a negative return on equity of 52.30%. The company’s revenue for the quarter was up 32.3% compared to the same quarter last year. Equities research analysts expect that Sientra, Inc. will post ($2.94) EPS for the current year.
Several large investors have recently bought and sold shares of SIEN. Wells Fargo & Company MN raised its holdings in shares of Sientra by 0.3% in the 1st quarter. Wells Fargo & Company MN now owns 12,871 shares of the medical instruments supplier’s stock worth $108,000 after purchasing an additional 40 shares during the period. Bank of New York Mellon Corp raised its holdings in shares of Sientra by 0.5% in the 1st quarter. Bank of New York Mellon Corp now owns 51,760 shares of the medical instruments supplier’s stock worth $436,000 after purchasing an additional 250 shares during the period. Ameriprise Financial Inc. raised its holdings in shares of Sientra by 18.0% in the 1st quarter. Ameriprise Financial Inc. now owns 659,859 shares of the medical instruments supplier’s stock worth $5,555,000 after purchasing an additional 100,445 shares during the period. Parametric Portfolio Associates LLC raised its holdings in shares of Sientra by 14.4% in the 1st quarter. Parametric Portfolio Associates LLC now owns 16,410 shares of the medical instruments supplier’s stock worth $138,000 after purchasing an additional 2,065 shares during the period. Finally, Schroder Investment Management Group raised its holdings in shares of Sientra by 146.1% in the 1st quarter. Schroder Investment Management Group now owns 417,733 shares of the medical instruments supplier’s stock worth $3,442,000 after purchasing an additional 247,992 shares during the period. 77.61% of the stock is currently owned by institutional investors.
TRADEMARK VIOLATION WARNING: This piece of content was first published by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another site, it was stolen and reposted in violation of US & international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dailypolitical.com/2017/09/15/sientra-inc-sien-sees-strong-trading-volume.html.
Sientra Company Profile
Sientra, Inc is a medical aesthetics company. The Company’s primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons.
Receive News & Ratings for Sientra Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sientra Inc. and related companies with MarketBeat.com's FREE daily email newsletter.